EG15085A - Process for preparation of spiro-quinolyhydantions derivatives for aldose inhibitors - Google Patents

Process for preparation of spiro-quinolyhydantions derivatives for aldose inhibitors

Info

Publication number
EG15085A
EG15085A EG36/80A EG3680A EG15085A EG 15085 A EG15085 A EG 15085A EG 36/80 A EG36/80 A EG 36/80A EG 3680 A EG3680 A EG 3680A EG 15085 A EG15085 A EG 15085A
Authority
EG
Egypt
Prior art keywords
quinolyhydantions
spiro
derivatives
preparation
aldose
Prior art date
Application number
EG36/80A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG15085A publication Critical patent/EG15085A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EG36/80A 1979-01-22 1980-01-12 Process for preparation of spiro-quinolyhydantions derivatives for aldose inhibitors EG15085A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,278 US4176185A (en) 1979-01-22 1979-01-22 Spiro-quinolylhydantoins

Publications (1)

Publication Number Publication Date
EG15085A true EG15085A (en) 1986-12-30

Family

ID=21715098

Family Applications (1)

Application Number Title Priority Date Filing Date
EG36/80A EG15085A (en) 1979-01-22 1980-01-12 Process for preparation of spiro-quinolyhydantions derivatives for aldose inhibitors

Country Status (22)

Country Link
US (1) US4176185A (fr)
EP (1) EP0014079B1 (fr)
JP (1) JPS5840959B2 (fr)
KR (1) KR830001940A (fr)
AR (1) AR222685A1 (fr)
AT (1) AT365588B (fr)
AU (1) AU514271B2 (fr)
CA (1) CA1140928A (fr)
DE (1) DE3060079D1 (fr)
DK (1) DK156399C (fr)
EG (1) EG15085A (fr)
ES (1) ES487923A0 (fr)
FI (1) FI69308C (fr)
GR (1) GR72408B (fr)
IE (1) IE49365B1 (fr)
IL (1) IL59177A (fr)
NO (1) NO152172C (fr)
NZ (1) NZ192650A (fr)
PH (1) PH15472A (fr)
PT (1) PT70716A (fr)
YU (1) YU41692B (fr)
ZA (1) ZA80344B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3261684D1 (en) * 1981-05-12 1985-02-07 Ici Plc Pyrrole derivatives
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3876659A (en) * 1970-09-18 1975-04-08 Sandoz Ag Spiro tricyclic isoindolines
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins

Also Published As

Publication number Publication date
US4176185A (en) 1979-11-27
PH15472A (en) 1983-01-24
IE800109L (en) 1980-07-22
ES8103090A1 (es) 1981-02-16
EP0014079B1 (fr) 1981-11-18
NO794318L (no) 1980-07-23
FI69308C (fi) 1986-01-10
DK156399B (da) 1989-08-14
CA1140928A (fr) 1983-02-08
JPS5840959B2 (ja) 1983-09-08
AT365588B (de) 1982-01-25
NO152172C (no) 1985-08-14
FI69308B (fi) 1985-09-30
DK24280A (da) 1980-07-23
GR72408B (fr) 1983-11-02
DE3060079D1 (en) 1982-01-21
IL59177A (en) 1982-11-30
YU41692B (en) 1987-12-31
ES487923A0 (es) 1981-02-16
ZA80344B (en) 1981-02-25
AU514271B2 (en) 1981-01-29
PT70716A (en) 1980-02-01
AR222685A1 (es) 1981-06-15
EP0014079A1 (fr) 1980-08-06
DK156399C (da) 1990-01-08
NO152172B (no) 1985-05-06
IL59177A0 (en) 1980-05-30
FI800163A (fi) 1980-07-23
KR830001940A (ko) 1983-05-19
NZ192650A (en) 1984-04-27
JPS55108873A (en) 1980-08-21
YU13180A (en) 1983-01-21
ATA26780A (de) 1981-06-15
AU5476680A (en) 1980-07-31
IE49365B1 (en) 1985-09-18

Similar Documents

Publication Publication Date Title
YU42075B (en) Process for obtaining new derivatives of 6-beta - hydroxyalkyl penicillinates
BG31499A3 (en) Method for obtaining of 1- vinyl- triazol derivatives
YU42655B (en) Process for obtaining derivatives of carboxialkyldipeptides
YU42172B (en) Process for obtaining new derivatives of 4-amino-5-alkyl-sulphonyl-orthdanizamide
PL238035A1 (en) Process for preparing novel derivatives of thiazole
YU201080A (en) Process for preparing 3-aminopropoxyaryl derivatives of indole
YU136880A (en) Process for obtaining new derivatives of 3-vinyl-cephalosporin
PT72152A (en) Process for preparing derivatives of a-30912h nucleus
DE3064993D1 (en) Process for the preparation of hexahydronaphthacene derivatives
GR63697B (en) Process for derivatives preparation of phenyl-alamine
EG15085A (en) Process for preparation of spiro-quinolyhydantions derivatives for aldose inhibitors
PT71582A (en) Process for the preparation of 3-methyleneazetidine derivatives
PH22005A (en) Process for the preparation of new hemoserine derivatives
EG14763A (en) Process for preparing of thiazoline derivatives
EG13472A (en) Improved process for preparation of 1-substituted kanamycin derivatives
BG32849A3 (en) Method for obtaining of 2- chlor- 4- substituated derivatives of thiazolcarbonic acids
BG33292A3 (en) Method for obtaining of penamsulphooxide derivatives
HRP930340B1 (en) Process for the preparation of morpholine derivatives
GR63658B (en) Process for derivatives preparation of naphyridine
YU278580A (en) Process for preparing new derivatives of 1-oxadethiacephalosporin
HU178397B (en) Process for preparing substituted derivatives of steroid-spiro-oxazolidione derivatives
YU43123B (en) Process for obtaining substituted derivatives of acylcarbamides
YU156883A (en) Process for preparing substituted derivatives of phenoxyamino-propanol
PT67617B (en) Process for preparing of azotizinone derivatives
GB2036017B (en) Selective process for the preparation of 7-hydroxycoumarin derivatives